BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,332,000 | +21.0% | 48,503 | +16.6% | 5.92% | -15.4% |
| Q2 2022 | $6,062,000 | +1842.9% | 41,603 | +1480.1% | 7.00% | +2462.6% |
| Q1 2022 | $312,000 | -14.5% | 2,633 | -0.6% | 0.27% | +28.2% |
| Q4 2021 | $365,000 | +9.6% | 2,650 | +10.4% | 0.21% | -6.2% |
| Q3 2021 | $333,000 | +55.6% | 2,400 | +9.1% | 0.23% | +63.3% |
| Q2 2021 | $214,000 | -16.7% | 2,200 | -53.4% | 0.14% | -72.7% |
| Q4 2019 | $257,000 | -48.6% | 4,721 | -60.7% | 0.51% | -26.7% |
| Q3 2019 | $500,000 | -23.4% | 12,000 | -19.5% | 0.70% | -22.4% |
| Q2 2019 | $653,000 | – | 14,900 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |